Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors.
Clinical trial NCT07615413 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07615413
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2029-06-30
- Enrollment
- 636
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.